Financials
- Market Capitalization 1.17 B
- Employee 260
- Founded 2014
- CEO N/A
- Website www.kuraoncology.com
- Headquarter Delaware, United States
- FIGI BBG008974342
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-3.26
Rapporto prezzo/fatturato
12.53
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 2334 | JANX Janux Therapeutics, Inc. - Common Stock | 19.82 USD | +0.61% | +5.54% | +28.53% | -15.26% | 1.21 B USD | ||
| 2340 | CRVS Corvus Pharmaceuticals, Inc. - Common Stock | 14.65 USD | +3.17% | +0.34% | +7.17% | +155.67% | 1.23 B USD | ||
| 2356 | SANA Sana Biotechnology, Inc. - Common Stock | 3.92 USD | +0.77% | -4.16% | +20.99% | +31.10% | 1.17 B USD | ||
| 2396 | SLDB Solid Biosciences Inc. - Common Stock | 10.42 USD | +1.26% | +2.86% | +26.92% | +82.81% | 1.12 B USD |